INVOKAMET 150-500 MG TABLET

canagliflozin and metformin hydrochloride
$9.6054per EA

Strength

150; 500 mg/1; mg/1

NDC

50458054260

Classification

Brand

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

4/22/2026

Approval Type

New Drug (NDA)

FDA Application

NDA204353

On Market Since

8/8/2014

Pharmacological Classes

Biguanide
Biguanides
P-Glycoprotein Inhibitors
Sodium-Glucose Cotransporter 2 Inhibitor
Sodium-Glucose Transporter 2 Inhibitors

Price History

1W

0.0%

1M

0.0%

3M

-0.1%

6M

+0.6%

1Y

+0.5%

3Y

+1.3%

5Y

+10.6%

All

+74.5%